Sinovac

Serious adverse events that occur in drug trials include death, immediate risk of death, long term or serious incapacitation, and hospitalization. read more

The result is only preliminary and researchers will keep monitoring the participants in the on-going trial, Covas said. It’s the first set of results of Sinovac’s Phase 3 global trials, which are also being conducted in Turkey and Indonesia. read more

The city of Jiaxing, south of Shanghai, is offering a vaccine under development by Sinovac, it said in an announcement Thursday. read more

Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July. read more

According to a registration record published on Wednesday, 552 healthy participants aged between three and 17 will take two doses of US-listed Sinovac’s CoronaVac or a placebo in a combined Phase 1 and Phase 2 trial estimated to begin on September 28 in the northern Chinese province of Hebei. read more

Health officials have been concerned about whether experimental vaccines could safely protect the elderly, whose immune systems usually react less robustly to vaccines, against the virus that has led to nearly 890,000 deaths worldwide. read more

Indonesia began the third phase of a Covid-19 vaccine trial made by China’s Sinovac Biotech Ltd. with a target to begin commercial production in six months. read more

Beijing has mobilized its health authorities, drug regulators and research institutes to work around the clock with local companies to come up with the world’s first effective vaccine for Covid-19. read more